• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一例晚期非小细胞肺癌患者中,使用痰液细胞学通过新型二代测序肺癌检测组合诊断试剂盒检测到EML4-ALK基因突变

EML4-ALK Gene Mutation Detected with New NGS Lung Cancer Panel CDx Using Sputum Cytology in a Case of Advanced NSCLC.

作者信息

Morikawa Kei, Kinoshita Kohei, Matsuzawa Shin, Kida Hirotaka, Handa Hiroshi, Inoue Takeo, Nakamura Seiji, Sato Yoshiharu, Mineshita Masamichi

机构信息

Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.

DNA Chip Research Inc., Tokyo 105-0022, Japan.

出版信息

Diagnostics (Basel). 2023 Jul 10;13(14):2327. doi: 10.3390/diagnostics13142327.

DOI:10.3390/diagnostics13142327
PMID:37510070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378045/
Abstract

The detection of driver gene mutations has become essential for lung cancer; however, insufficient sample sizes make gene panel tests difficult to use. We previously reported that the lung cancer compact panel TM (LCCP) could detect EGFR and MET gene mutations with sputum cytology. To date, the detection of gene mutation using RNA from sputum samples is considered practically difficult. We report a case in which the EML4-ALK fusion gene was successfully detected from a sputum sample using the LCCP that was just released in Japan as a new next-generation sequencing lung cancer panel, CDx.

摘要

驱动基因突变的检测已成为肺癌诊断的关键环节;然而,样本量不足使得基因检测面板难以应用。我们之前报道过肺癌紧凑型检测面板TM(LCCP)可通过痰液细胞学检测EGFR和MET基因突变。迄今为止,从痰液样本RNA中检测基因突变在实际操作中仍颇具难度。我们报告了一个病例,使用在日本刚刚作为新一代测序肺癌检测面板CDx发布的LCCP,成功从痰液样本中检测到EML4-ALK融合基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/27644de42756/diagnostics-13-02327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/ab34585e17e1/diagnostics-13-02327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/9ed9e2db5a42/diagnostics-13-02327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/27644de42756/diagnostics-13-02327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/ab34585e17e1/diagnostics-13-02327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/9ed9e2db5a42/diagnostics-13-02327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bb/10378045/27644de42756/diagnostics-13-02327-g003.jpg

相似文献

1
EML4-ALK Gene Mutation Detected with New NGS Lung Cancer Panel CDx Using Sputum Cytology in a Case of Advanced NSCLC.在一例晚期非小细胞肺癌患者中,使用痰液细胞学通过新型二代测序肺癌检测组合诊断试剂盒检测到EML4-ALK基因突变
Diagnostics (Basel). 2023 Jul 10;13(14):2327. doi: 10.3390/diagnostics13142327.
2
Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.利用支气管镜检查时即时细胞学检查,从经支气管细胞学标本中的少量癌细胞中检测 EML4-ALK 融合基因。
Lung Cancer. 2012 Aug;77(2):293-8. doi: 10.1016/j.lungcan.2012.03.018. Epub 2012 Apr 10.
3
Comparison of EML4-ALK fusion gene positive rate in different detection methods and samples of non-small cell lung cancer.不同检测方法及非小细胞肺癌样本中EML4-ALK融合基因阳性率的比较
J Cancer. 2020 Jan 14;11(6):1525-1531. doi: 10.7150/jca.36580. eCollection 2020.
4
Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.中国非小细胞肺癌中靶向下一代测序鉴定的驱动基因的基因组特征。
Oncologist. 2019 Nov;24(11):e1070-e1081. doi: 10.1634/theoncologist.2018-0572. Epub 2019 Mar 22.
5
Lung adenocarcinoma harboring complex EML4-ALK fusion and BRAF V600E co-mutation responded to alectinib.肺腺癌伴复杂 EML4-ALK 融合和 BRAF V600E 共突变对艾乐替尼有反应。
Medicine (Baltimore). 2022 Oct 7;101(40):e30913. doi: 10.1097/MD.0000000000030913.
6
Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.检测具有 EGFR 突变相关临床特征的非小细胞肺癌患者中的 EML4-ALK 融合基因。
Genes Chromosomes Cancer. 2012 Oct;51(10):925-32. doi: 10.1002/gcc.21976. Epub 2012 Jun 27.
7
Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs.使用非小细胞肺癌(NSCLC)痰细胞学进行下一代测序(NGS)基因 panel 检测的初步结果及其相应的分子靶向药物治疗效果。
Genes (Basel). 2022 May 2;13(5):812. doi: 10.3390/genes13050812.
8
Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma.肺腺癌中新型 RMDN2-ALK 融合和 EML4-ALK 融合的共存。
Cancer Genet. 2021 Nov;258-259:18-22. doi: 10.1016/j.cancergen.2021.06.004. Epub 2021 Jun 23.
9
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.印度肺癌腺癌患者中表皮生长因子受体(EGFR)突变和棘皮动物微管相关蛋白样4(EML4)-间变性淋巴瘤激酶(ALK)融合基因的临床与流行病学研究
Onco Targets Ther. 2015 Jan 5;8:117-23. doi: 10.2147/OTT.S74820. eCollection 2015.
10
Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer.208 例中国非小细胞肺癌患者中 EML4-ALK 融合基因的临床意义及其与 EGFR 和 KRAS 基因突变的关系。
PLoS One. 2013;8(1):e52093. doi: 10.1371/journal.pone.0052093. Epub 2013 Jan 14.

引用本文的文献

1
Clinical utility of rapid on-site evaluation of brush cytology during bronchoscopy using endobronchial ultrasound with a guide sheath.经支气管超声内镜引导鞘内刷检行快速现场细胞学评估在支气管镜检查中的临床应用
Sci Rep. 2024 Sep 12;14(1):21334. doi: 10.1038/s41598-024-72138-z.

本文引用的文献

1
Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics.用于肺癌伴随诊断的高灵敏度系统利用下一代测序检测基因变异的分析性能
Diagnostics (Basel). 2023 Apr 19;13(8):1476. doi: 10.3390/diagnostics13081476.
2
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens.一项使用细胞学标本进行肺癌基因检测板检测的前瞻性验证研究。
Cancers (Basel). 2022 Aug 3;14(15):3784. doi: 10.3390/cancers14153784.
3
Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs.
使用非小细胞肺癌(NSCLC)痰细胞学进行下一代测序(NGS)基因 panel 检测的初步结果及其相应的分子靶向药物治疗效果。
Genes (Basel). 2022 May 2;13(5):812. doi: 10.3390/genes13050812.
4
Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.基于 4467 例 NSCLC 患者,对 NGS 和 ARMS-PCR 检测 EGFR 突变的综合分析。
J Cancer Res Clin Oncol. 2022 Feb;148(2):321-330. doi: 10.1007/s00432-021-03818-w. Epub 2021 Oct 24.
5
Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR.采用液滴数字 PCR 检测痰标本中肺腺癌的 EGFR 突变。
BMC Pulm Med. 2021 Mar 23;21(1):100. doi: 10.1186/s12890-021-01468-9.
6
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.采用液滴数字PCR检测EGFR突变型非小细胞肺癌患者痰液中EGFR激活突变和耐药突变
Clin Med Insights Oncol. 2021 Feb 17;15:1179554921993072. doi: 10.1177/1179554921993072. eCollection 2021.
7
Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.晚期 NSCLC 患者血浆、痰液、尿液与肿瘤组织中游离 DNA 的基因组图谱差异。
Cancer Med. 2019 Mar;8(3):910-919. doi: 10.1002/cam4.1935. Epub 2019 Feb 14.
8
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.IV 期非小细胞肺癌的系统治疗:美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2017 Oct 20;35(30):3484-3515. doi: 10.1200/JCO.2017.74.6065. Epub 2017 Aug 14.
9
Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.肺癌的诊断:肺癌的诊断与管理,第 3 版:美国胸科医师学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e142S-e165S. doi: 10.1378/chest.12-2353.
10
Sputum cytology for the detection of early lung cancer.用于检测早期肺癌的痰液细胞学检查。
Curr Opin Pulm Med. 2003 Jul;9(4):309-12. doi: 10.1097/00063198-200307000-00011.